Are you the organiser of this event?

    • Biosimilars development sits at the intersection of regulatory approval, analytical characterisation and manufacturing scale-up, and a focused congregation puts suppliers in front of the people who own those decisions.
    • Exhibiting gives you direct access to development, quality and regulatory teams from biosimilar developers and their partners.
    • A single-day format keeps the audience concentrated, so stand conversations tend to be technical and specific rather than casual.

    Audience at a Glance

    Who Exhibits

    Exhibitor Profile

    8 categories represented

    • Analytical and bioanalytical instrumentation
    • Contract research and development services
    • Contract manufacturing and fill-finish
    • Cell line and expression system suppliers
    • Regulatory and compliance consultancies
    • Process chromatography and filtration
    • Quality control and stability testing services
    • Bioreactor and upstream equipment

    Who Attends

    Visitor Profile

    8 audience types

    • Biosimilar development scientists
    • Regulatory affairs professionals
    • Quality control and analytical leads
    • Manufacturing and process engineers
    • Formulation and CMC specialists
    • Procurement and sourcing managers
    • Clinical and pharmacovigilance staff
    • Biopharma business development executives

    Industries & Sectors

    PharmaceuticalsBiopharmaceuticalsBiosimilars

    Coverage & Spotlights

    No exhibitor spotlights published yet for this event.

    Be the first exhibitor featured at this event →

    Enquiry

    Want details on BIOSIMILARS CONGREGATION 2026 — agenda, exhibiting, or attending?

    Drop your details and we'll forward your enquiry to the event organizers. They'll get back to you within 1–2 business days.

    Your info is shared only with the event organizers and the TSI team.

    This event listing on TradeShowIntel was last updated: .